ArticleInternational journal of clinical pharmacy2025

A real-world pharmacovigilance study of belzutifan in renal cell carcinoma and von Hippel-Lindau disease: insights from the FDA adverse event reporting system database.

Yang Ye et al.PubMed ↗Publisher ↗

No numbers read from the abstract.